Inventor · disambiguated record
Craig Erickson
Also filed as: ERICKSON CRAIG · ERICKSON CRAIG A · ERICKSON CRAIG ANDREW
10 granted patents·8 pending applications·19 citations·filing 2010–2025
85Inventor score
Files withCHILDRENS HOSPITAL MED CT8UNIV INDIANA RES & TECH CORP4CHILDREN'S HOSPITAL MEDICAL CENTER3CONFLUENCE PHARMACEUTICALS LLC2ERICKSON CRAIG A1
Top patents by PatentIndex Score
18 records- 0187US9844551B2Compositions and methods for treatment of fragile X syndromeCHILDREN'S HOSPITAL MEDICAL CENTER·Filed 2016·Granted Dec 19, 2017·4 cites·8 claims
- 0286US10159673B2Compositions and methods for treatment of Fragile X SyndromeCHILDRENS HOSPITAL MED CT·Filed 2017·Granted Dec 25, 2018·3 cites·9 claims
- 0382US11311539B2Compositions and methods for treatment of fragile X syndromeCHILDRENS HOSPITAL MED CT·Filed 2019·Granted Apr 26, 2022·1 cites·12 claims
- 0481US10588905B2Compositions and methods for treatment of fragile X syndromeCHILDRENS HOSPITAL MED CT·Filed 2018·Granted Mar 17, 2020·1 cites·20 claims
- 0578US9610259B2Compositions and methods for treating an autism spectrum disorderCHILDREN'S HOSPITAL MEDICAL CENTER·Filed 2015·Granted Apr 4, 2017·5 cites·14 claims
- 0673US9770423B2Modulation sAPP, sAAPα and BDNF levels in individuals diagnosed with FXS and ASDUNIV INDIANA RES & TECH CORP·Filed 2013·Granted Sep 26, 2017·3 cites·21 claims
- 0768US10634677B2Use of acamprosate to modulate ERK1/2 activation in animal models for FXS and ASD and individuals diagnosed with FXS and ASDUNIV INDIANA RES & TECH CORP·Filed 2014·Granted Apr 28, 2020·1 cites·7 claims
- 0861US11733243B2Use of acamprosate to modulate ERK1/2 activation in animal models for FXS and ASD and individuals diagnosed with FXS and ASDUNIV INDIANA RES & TECH CORP·Filed 2020·Granted Aug 22, 2023·0 cites·7 claims
- 0961US9463172B2Material and methods for treating developmental disorders including comorbid and idiopathic autismERICKSON CRAIG A·Filed 2010·Granted Oct 11, 2016·1 cites·27 claims
- 1055US2021251997A1Paliperidone for treatment of drug refractory irritability and autism spectrum disorderCHILDRENS HOSPITAL MED CT·Filed 2021·Application pending·0 cites
- 1154US2023414611A1Refined uses of gaba a receptor modulators in treatment of fragile x syndromeCHILDRENS HOSPITAL MED CT·Filed 2021·Application pending·0 cites
- 1253US2025313896A1Methods for evaluating a subject for fragile x syndromeCHILDRENS HOSPITAL MED CT·Filed 2025·Application pending·0 cites
- 1351US9956189B2Material and methods for treating developmental disorders including comorbid and idiopathic autismUNIV INDIANA RES & TECH CORP·Filed 2016·Granted May 1, 2018·0 cites·23 claims
- 1451US2023295654A1Methods and compositions for treatment of fragile x syndromeCHILDRENS HOSPITAL MED CT·Filed 2021·Application pending·0 cites
- 1549US2019321367A1Paliperidone for treatment of drug refractory irritability and autism spectrum disorderCHILDRENS HOSPITAL MED CT·Filed 2017·Application pending·0 cites
- 1646US2020360316A1Combination therapy using acamprosate and d-cycloserineCONFLUENCE PHARMACEUTICALS LLC·Filed 2020·Application pending·0 cites
- 1743US2018221315A1Combination therapy using acamprosate and d-cycloserineCONFLUENCE PHARMACEUTICALS LLC·Filed 2016·Application pending·0 cites
- 1838US2017095429A1Compositions and methods for treating an autism spectrum disorderCHILDREN'S HOSPITAL MEDICAL CENTER·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Craig Erickson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →